Exchange: NASDAQ Global Select Sector: Healthcare Industry: Medical - Healthcare Information Services
Current Signal: BUY (auto-tracking)
0.34% $86.24
/ 26 apr 2024 @ 16:00
FUNDAMENTALS | |
---|---|
MarketCap: | 39 270 mill |
EPS: | 3.04 |
P/E: | 28.37 |
Earnings Date: | Apr 30, 2024 |
SharesOutstanding: | 455.36 mill |
Avg Daily Volume: | 3.47 mill |
RATING 2024-04-26 |
---|
S- |
Strong Buy |
RATINGS | ||
---|---|---|
Rating CashFlow: | Buy | |
Return On Equity: | Strong Buy | |
Return On Asset: | Buy | |
DE: | Strong Buy | |
P/E: | Buy | |
Price To Book: | Buy |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
Revenue | ||||||
Gr.Profit | ||||||
Ebit | ||||||
Asset | ||||||
Debt |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE 28.37 | sector: PE 0 |
PE RATIO: COMPANY / INDUSTRY |
---|
0x |
Company: PE 28.37 | industry: PE 0 |
DISCOUNTED CASH FLOW VALUE |
---|
$56.28 (-34.75%) $-29.96 |
Date: 2024-04-27 |
Expected Trading Range (DAY) |
---|
$ 84.31 - 88.17 ( +/- 2.24%) |
ATR Model: 14 days |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-01 | Rott Roland | Sell | 837 | Common Stock, par value $0.01 per share |
2024-03-15 | General Electric Co | Sell | 14 000 000 | Common stock, par value $0.01 per share |
2024-03-01 | Westrick Thomas J. | Sell | 1 195 | Common Stock, par value $0.01 per share |
2024-03-01 | Westrick Thomas J. | Sell | 1 285 | Common Stock, par value $0.01 per share |
2024-03-01 | Westrick Thomas J. | Buy | 2 965 | Common Stock, par value $0.01 per share |
INSIDER POWER |
---|
-97.67 |
Last 99 transactions |
Buy: 734 614 | Sell: 57 995 156 |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 | |
MACD |
Volume Signals | |
---|---|
Price | $86.24 (0.34% ) |
Volume | 1.724 mill |
Avg. Vol. | 3.47 mill |
% of Avg. Vol | 49.63 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % | Feb 8 - 15:35 | sell | $81.79 | N/A | Active |
---|
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, Hong Kong, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, and X-ray systems, as well as women's health products. The Ultrasound segment provides screening, diagnosis, treatment, and monitoring of certain diseases through radiology and primary care, women's health, cardiovascular, and point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products. The Patient Care Solutions segment involved in the provision of medical devices, consumable products, services, and digital solutions through patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, and maternal infant care products. The Pharmaceutical Diagnostics supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound to the radiology and nuclear medicine industry. The segment also provides contrast media pharmaceuticals, administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents, or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes that are injected into a patient prior to a diagnostic imaging scan. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.